Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Oldham Global is a private consulting, advisory, and investment-oriented company founded in 2017 by Bill Oldham. The firm supports entrepreneurial businesses across health, specialty pharma, fintech, and technology services rather than operating as a drug developer with its own therapeutic pipeline. Public descriptions indicate that it functions as a development company and quasi-family office, with interests spanning healthcare, pharmacy, logistics, fintech, and clinical staffing. In healthcare, its activities appear focused on strategy, business building, financing, portfolio support, and health-related operating companies rather than discovery or clinical-stage therapeutics. The company has highlighted partnerships around healthcare outcomes, specialty pharma, and pharmaceutical financing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Oldham Global.